Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) EPS (Weighted Average and Diluted): 2021-2025

Historic EPS (Weighted Average and Diluted) for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Sep 2025 value amounting to $0.23.

  • Kiniksa Pharmaceuticals International's EPS (Weighted Average and Diluted) rose 227.78% to $0.23 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.45, marking a year-over-year increase of 446.15%. This contributed to the annual value of -$0.60 for FY2024, which is 400.00% down from last year.
  • As of Q3 2025, Kiniksa Pharmaceuticals International's EPS (Weighted Average and Diluted) stood at $0.23, which was down 0.00% from $0.23 recorded in Q2 2025.
  • In the past 5 years, Kiniksa Pharmaceuticals International's EPS (Weighted Average and Diluted) registered a high of $3.18 during Q3 2022, and its lowest value of -$0.72 during Q1 2021.
  • For the 3-year period, Kiniksa Pharmaceuticals International's EPS (Weighted Average and Diluted) averaged around $0.01, with its median value being -$0.06 (2024).
  • Per our database at Business Quant, Kiniksa Pharmaceuticals International's EPS (Weighted Average and Diluted) spiked by 822.73% in 2022 and then tumbled by 133.33% in 2024.
  • Kiniksa Pharmaceuticals International's EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.52 in 2021, then soared by 109.62% to $0.05 in 2022, then surged by 620.00% to $0.36 in 2023, then slumped by 133.33% to -$0.12 in 2024, then spiked by 227.78% to $0.23 in 2025.
  • Its last three reported values are $0.23 in Q3 2025, $0.23 for Q2 2025, and $0.11 during Q1 2025.